Amneal Pharmaceuticals (AMRX) Net Margin (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted Net Margin of 8.74% for Q2 2026, down 19.01% on a QoQ basis from 10.8% in Q1 2026, and up 383.0% year-over-year from 1.81% in Q2 2025.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Net Margin (2018 - 2026) Analysis & Trends
Amneal Pharmaceuticals has reported Net Margin for 9 years, with the latest figure at 8.74% in Q2 2026.
- On a quarterly basis, Net Margin rose 383.0% year-over-year to 8.74% in Q2 2026; TTM through Jun 2026 was 6.91%, a 511.0% increase from a year earlier, with the FY2025 full-year figure at 4.24%, up 842.0% from the prior year.
- Net Margin was 8.74% for Q2 2026 at Amneal Pharmaceuticals, down from 10.8% in the prior quarter.
- The five-year high for Net Margin was 10.8% in Q1 2026, with the low at 21.6% in Q2 2022.
- Average Net Margin over 5 years is 0.65%, with a median of 1.62% recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Net Margin slumped 2431 bps in 2022, then soared 2359 bps in 2023.
- Over 5 years, Net Margin stood at 0.71% in 2022, then plunged by 2150 bps to 15.99% in 2023, then soared by 82 bps to 2.84% in 2024, then surged by 314 bps to 6.09% in 2025, then surged by 44 bps to 8.74% in 2026.
- The last three Net Margin figures came in at 8.74% (Q2 2026), 10.8% (Q1 2026), and 6.09% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.23 Bn | 38.58 Bn | 2.15 Bn | -13.91% |
| 2 | Viatris | 18.97 Bn | 18.08 Bn | 1.46 Bn | -3.16% |
| 3 | Dr Reddys Laboratories | 9.80 Bn | 9.63 Bn | 396.53 Mn | 5.50% |
| 4 | Amneal Pharmaceuticals | 5.39 Bn | 5.26 Bn | 334.51 Mn | 8.74% |
| 5 | Bausch Health Companies | 2.28 Bn | 443.88 Mn | 2.10 Bn | 9.12% |
| 6 | Alvotech | 1.53 Bn | 1.39 Bn | 2.56 Mn | -121.81% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 9.28% |
| 8 | Amphastar Pharmaceuticals | 1.02 Bn | 728.53 Mn | 93.47 Mn | 16.50% |
| 9 | Fennec Pharmaceuticals | 392.67 Mn | 351.42 Mn | 17.15 Mn | 11.04% |
| 10 | RedHill Biopharma | 172.24 Mn | 172.24 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.74% |
| Mar 31, 2026 | 10.80% |
| Dec 31, 2025 | 6.09% |
| Sep 30, 2025 | 2.31% |
| Jun 30, 2025 | 4.92% |
| Mar 31, 2025 | 3.54% |
| Dec 31, 2024 | -2.84% |
| Sep 30, 2024 | 1.67% |
| Jun 30, 2024 | 2.39% |
| Mar 31, 2024 | -12.39% |
| Dec 31, 2023 | -15.99% |
| Sep 30, 2023 | 1.56% |
| Jun 30, 2023 | 1.99% |
| Mar 31, 2023 | -1.25% |
| Dec 31, 2022 | -0.71% |
| Sep 30, 2022 | -0.49% |
| Jun 30, 2022 | -21.60% |
| Mar 31, 2022 | -0.43% |
| Dec 31, 2021 | -1.19% |
| Sep 30, 2021 | -0.80% |